John B. Sanfilippo & Son (NASDAQ:JBSS – Get Free Report) will post its quarterly earnings results after the market closes on Wednesday, May 1st. Parties that wish to listen to the company’s conference call can do so using this link.
John B. Sanfilippo & Son (NASDAQ:JBSS – Get Free Report) last announced its quarterly earnings data on Wednesday, January 31st. The company reported $1.64 earnings per share (EPS) for the quarter. The business had revenue of $291.22 million during the quarter. John B. Sanfilippo & Son had a net margin of 6.73% and a return on equity of 22.78%.
John B. Sanfilippo & Son Trading Down 0.1 %
Shares of JBSS traded down $0.07 during mid-day trading on Tuesday, reaching $99.99. 7,745 shares of the company’s stock traded hands, compared to its average volume of 57,275. The company has a debt-to-equity ratio of 0.02, a current ratio of 2.26 and a quick ratio of 0.72. The stock’s 50-day moving average is $101.93 and its two-hundred day moving average is $100.67. John B. Sanfilippo & Son has a 12 month low of $90.02 and a 12 month high of $127.26. The stock has a market cap of $1.16 billion, a P/E ratio of 17.37 and a beta of 0.05.
About John B. Sanfilippo & Son
John B. Sanfilippo & Son, Inc, through its subsidiary, JBSS Ventures, LLC, processes and distributes tree nuts and peanuts in the United States. The company offers raw and processed nuts, including almonds, pecans, peanuts, black walnuts, English walnuts, cashews, macadamia nuts, pistachios, pine nuts, Brazil nuts, and filberts in various styles and seasonings.
See Also
- Five stocks we like better than John B. Sanfilippo & Son
- Stock Average Calculator
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- 3 Warren Buffett Stocks to Buy Now
- Hilton Demonstrates Asset Light is Right for Investors
- What is the S&P/TSX Index?
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for John B. Sanfilippo & Son Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for John B. Sanfilippo & Son and related companies with MarketBeat.com's FREE daily email newsletter.